Tofacitinib Citrate
Tofacitinib citrate is a potent and cell-permeable Janus kinase (JAK) inhibitor with selectivity for JAK1, JAK2, and JAK3. It is widely used in both in vitro and in vivo research to investigate JAK-STAT signaling pathways in immunology, inflammation, and autoimmune disease models.
Product Specifications
CAS Number
540737-29-9
Product Name Alternative
Tofacitinib, Tofacitinib (CP-690550) Citrate, Tofacitinib Citrate, Tasocitinib, Tasocitinib citrate, Tasocitinib Citrate, JAK1, JAK2, JAK, Janus kinase, JAK3, inhibit, InfluenzaVirus, Influenza Virus, Fungal, Inhibitor, CP690550, CP-690550, CP690550 Citrate, CP-690550 Citrate, CP-690550 citrate, CP 690550, CP 690550 Citrate, Apoptosis, Bacterial
Field of Research
Cardiovascular Research, Cell Biology, Epigenetics & Chromatin, Infectious Disease & Virology, Pharmacology & Drug Discovery, Signal Transduction, Stem Cell & Developmental Biology
Purity
99.19% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.96 mM) ; DMSO:55 mg/mL (109.02 mM)
Smiles
OC (=O) CC (O) (CC (O) =O) C (O) =O.C[C@@H]1CCN (C[C@@H]1N (C) c1ncnc2[nH]ccc12) C (=O) CC#N
Molecular Formula
C22H28N6O8
Molecular Weight
504.49
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog